HJGA
Hardman Johnston Global Advisors’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1M | Sell |
233,504
-53,750
| -19% | -$5.77M | 1.11% | 29 |
|
|
2025
Q1 | $29M | Sell |
287,254
-39,650
| -12% | -$4M | 1.38% | 25 |
|
|
2024
Q4 | $29.2M | Buy |
326,904
+69,910
| +27% | +$6.24M | 1.21% | 29 |
|
|
2024
Q3 | $21.5M | Sell |
256,994
-97,550
| -28% | -$8.17M | 0.84% | 29 |
|
|
2024
Q2 | $27.3M | Sell |
354,544
-298,070
| -46% | -$23M | 1.06% | 29 |
|
|
2024
Q1 | $44.7M | Sell |
652,614
-22,326
| -3% | -$1.53M | 1.54% | 24 |
|
|
2023
Q4 | $39M | Buy |
674,940
+24,810
| +4% | +$1.43M | 1.25% | 27 |
|
|
2023
Q3 | $34.3M | Sell |
650,130
-94,390
| -13% | -$4.98M | 1.15% | 27 |
|
|
2023
Q2 | $40.3M | Sell |
744,520
-71,220
| -9% | -$3.85M | 1.31% | 27 |
|
|
2023
Q1 | $40.8M | Sell |
815,740
-3,500
| -0.4% | -$175K | 1.33% | 26 |
|
|
2022
Q4 | $37.9M | Sell |
819,240
-15,980
| -2% | -$739K | 1.48% | 24 |
|
|
2022
Q3 | $32.3M | Buy |
835,220
+201,720
| +32% | +$7.81M | 1.46% | 26 |
|
|
2022
Q2 | $23.6M | Buy |
633,500
+450
| +0.1% | +$16.8K | 1% | 35 |
|
|
2022
Q1 | $28M | Sell |
633,050
-168,370
| -21% | -$7.46M | 0.9% | 34 |
|
|
2021
Q4 | $34M | Buy |
801,420
+3,650
| +0.5% | +$155K | 0.92% | 30 |
|
|
2021
Q3 | $34.6M | Sell |
797,770
-4,750
| -0.6% | -$206K | 0.93% | 26 |
|
|
2021
Q2 | $34.3M | Buy |
802,520
+19,100
| +2% | +$817K | 0.83% | 28 |
|
|
2021
Q1 | $30.3M | Buy |
783,420
+171,790
| +28% | +$6.64M | 0.86% | 30 |
|
|
2020
Q4 | $22M | Sell |
611,630
-1,040
| -0.2% | -$37.4K | 0.64% | 39 |
|
|
2020
Q3 | $23.4M | Buy |
612,670
+81,160
| +15% | +$3.1M | 0.88% | 31 |
|
|
2020
Q2 | $18.7M | Buy |
531,510
+289,690
| +120% | +$10.2M | 0.82% | 39 |
|
|
2020
Q1 | $7.89M | Buy |
+241,820
| New | +$7.89M | 0.46% | 41 |
|